126 related articles for article (PubMed ID: 26343926)
1. Assay of serum CEACAM1 as a potential biomarker for breast cancer.
Yang C; He P; Liu Y; He Y; Yang C; Du Y; Zhou M; Wang W; Zhang G; Wu M; Gao F
Clin Chim Acta; 2015 Oct; 450():277-81. PubMed ID: 26343926
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of serum CEACAM1 in patients with pancreatic cancer].
Gong DY; Fu HX; Peng Y; You YQ; Li ZP
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):164-6. PubMed ID: 21269981
[TBL] [Abstract][Full Text] [Related]
3. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of carcinoembryonic antigen-related cell adhesion molecule 1 in gastrointestinal cancer and its clinical relevance.
Zhou M; Jin Z; Liu Y; He Y; Du Y; Yang C; Wang Y; Hu J; Cui L; Gao F; Cao M
Acta Biochim Biophys Sin (Shanghai); 2017 Aug; 49(8):737-743. PubMed ID: 28655144
[TBL] [Abstract][Full Text] [Related]
5. Clinical and experimental studies regarding the expression and diagnostic value of carcinoembryonic antigen-related cell adhesion molecule 1 in non-small-cell lung cancer.
Zhou MQ; Du Y; Liu YW; Wang YZ; He YQ; Yang CX; Wang WJ; Gao F
BMC Cancer; 2013 Jul; 13():359. PubMed ID: 23885995
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of CEACAM1 in breast cancer.
Yang C; He P; Liu Y; He Y; Yang C; Du Y; Zhou M; Wang W; Zhang G; Wu M; Gao F
Acta Biochim Biophys Sin (Shanghai); 2015 Oct; 47(10):788-94. PubMed ID: 26341981
[TBL] [Abstract][Full Text] [Related]
7. Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma.
Yu H; Yu J; Ren Y; Yang Y; Xiao X
PLoS One; 2016; 11(4):e0153601. PubMed ID: 27074014
[TBL] [Abstract][Full Text] [Related]
8. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.
Farina A; Dumonceau JM; Antinori P; Annessi-Ramseyer I; Frossard JL; Hochstrasser DF; Delhaye M; Lescuyer P
Biochim Biophys Acta; 2014 May; 1844(5):1018-25. PubMed ID: 23806607
[TBL] [Abstract][Full Text] [Related]
9. Significance of Some Non-Invasive Biomarkers in the Early Diagnosis and Staging of Egyptian Breast Cancer Patients.
Motawi TM; Zakhary NI; Darwish HA; Abdullah H; Tadros SA
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3279-3284. PubMed ID: 33247685
[TBL] [Abstract][Full Text] [Related]
10. Serum CD166: a novel hepatocellular carcinoma tumor marker.
Ma L; Lin J; Qiao Y; Weng W; Liu W; Wang J; Sun F
Clin Chim Acta; 2015 Feb; 441():156-62. PubMed ID: 25562819
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor of differentiation is overexpressed with progression of benign to malignant lesions and related with carcinoembryonic antigen-related cell adhesion molecule 1 distribution in mammary glands.
Liu Q; Yang YM; Zhang QH; Zhang TG; Zhou Q; Zhou CJ
Ann Diagn Pathol; 2011 Feb; 15(1):30-6. PubMed ID: 21106423
[TBL] [Abstract][Full Text] [Related]
12. CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis.
Markel G; Imazio M; Koren-Morag N; Galore-Haskel G; Schachter J; Besser M; Cumetti D; Maestroni S; Altman A; Shoenfeld Y; Brucato A; Adler Y
Oncotarget; 2016 Apr; 7(14):17885-95. PubMed ID: 26909604
[TBL] [Abstract][Full Text] [Related]
13. Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.
Kulasingam V; Zheng Y; Soosaipillai A; Leon AE; Gion M; Diamandis EP
Int J Cancer; 2009 Jul; 125(1):9-14. PubMed ID: 19322904
[TBL] [Abstract][Full Text] [Related]
14. Expression of carcinoembryonic antigen-related cell adhesion molecule 1(CEACAM1) and its correlation with angiogenesis in gastric cancer.
Shi JF; Xu SX; He P; Xi ZH
Pathol Res Pract; 2014 Aug; 210(8):473-6. PubMed ID: 24846314
[TBL] [Abstract][Full Text] [Related]
15. Serum Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in Patients with Hepatocellular Carcinoma.
Sripariwuth E; Piwchan S; Pongcharoen S
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3521-3524. PubMed ID: 34837908
[TBL] [Abstract][Full Text] [Related]
16. Loss of membranous carcinoembryonic antigen-related cell adhesion molecule 1 expression is related to decreased relapse-free survival of hepatocellular carcinoma following liver transplantation.
Sha QQ; Wei QZ; Zhu JK; Wang KX; Wang C; Liu HT; Yu WB; Li MX; Zhang GY
Chin Med J (Engl); 2012 Aug; 125(16):2841-5. PubMed ID: 22932077
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients.
Zhang Y; Cai P; Li L; Shi L; Chang P; Liang T; Yang Q; Liu Y; Wang L; Hu L
Int Immunopharmacol; 2017 Feb; 43():210-218. PubMed ID: 28038383
[TBL] [Abstract][Full Text] [Related]
18. Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms.
Gaur S; Shively JE; Yen Y; Gaur RK
Mol Cancer; 2008 May; 7():46. PubMed ID: 18507857
[TBL] [Abstract][Full Text] [Related]
19. Fucosyltransferase IV (FUT4) as an effective biomarker for the diagnosis of breast cancer.
Yan X; Lin Y; Liu S; Aziz F; Yan Q
Biomed Pharmacother; 2015 Mar; 70():299-304. PubMed ID: 25776515
[TBL] [Abstract][Full Text] [Related]
20. CEACAM1 in malignant melanoma: a diagnostic and therapeutic target.
Sapoznik S; Ortenberg R; Schachter J; Markel G
Curr Top Med Chem; 2012; 12(1):3-10. PubMed ID: 22196267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
